Beginner view — everything explained simply.
The detailed substance texts are currently available in German only. The interface and navigation are translated; the specialist content will follow in reviewed quality.
Research compounds
Detailed profiles of experimental compounds that are not peptides — synthetic molecules from neuroprotection, longevity and nootropics research. We explain origin, mechanism, the preclinical evidence and clinical status, and assess the regulatory standing honestly — with no dosing or usage information.
J-147
Synthetic small molecule (curcumin derivative, hydrazone structure)
Experimental neuroprotective drug candidate from the Salk Institute that targets the energy metabolism of the nerve cell rather than amyloid.
CMS121
Synthetic fisetin derivative (flavonoid analog) – not a peptide, small molecule
Salk research molecule (Maher/Schubert) derived from the plant compound fisetin – studied as a "geroneuroprotector" against brain aging and Alzheimer's.
CNB-001
Synthetic pyrazole-curcumin derivative – not a peptide, small molecule
Synthetic curcumin derivative from the Salk Institute – neuroprotective precursor of J-147, studied exclusively preclinically.
Dihexa
Synthetic angiotensin IV analog (N-acylated peptidomimetic) – not a natural peptide
A synthetic angiotensin IV derivative whose cognition-enhancing effect rests on a now-retracted research basis.

